2321
We have seen a case of terminal malignant melanoma in which clinical manifestations, indicative of anterior spinal artery syndrome, developed following the injection of 0.3 ml of 10% phenol-glycerine into the cervical subarachnoid space at the C4--C5 level for the control of severe right arm pain.
 terminal malignant melanoma in which clinical manifestations, indicative of anterior spinal artery syndrome: Effect; the injection of 0.3 ml of 10% phenol-glycerine into the cervical subarachnoid space at the C4--C5 level: Treatment; 10% phenol-glycerine: Treatment.Drug; severe right arm pain: Treatment.Disorder; injection: Treatment.Route; cervical subarachnoid space at the C4--C5 level: Treatment.Route; 0.3 ml: Treatment.Dosage
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 terminal malignant melanoma in which clinical manifestations, indicative of anterior spinal artery syndrome: Effect; the injection of 0.3 ml of 10% phenol-glycerine into the cervical subarachnoid space at the C4--C5 level: Treatment; 10% phenol-glycerine: Treatment.Drug; severe right arm pain: Treatment.Disorder; injection: Treatment.Route; cervical subarachnoid space at the C4--C5 level: Treatment.Route; 0.3 ml: Treatment.Dosage